Search

everythinglearnresearchcommunity

for

Search:↓

Atopic dermatitis increases the risk of some autoimmune diseases.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Hair conditions can be linked to diabetes and affect psychological health.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

About 61% of women who had COVID-19 experienced hair loss afterward.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

A girl with severe hair loss saw hair regrowth after using cannabis.

Early-stage Alopecia Areata was effectively treated in less than six months.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Current treatments for alopecia show no significant long-term benefits.

Alopecia areata treatment varies, with no optimal method established yet.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.